Browse recruiting and upcoming clinical trials for Evans syndrome.
Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026
About this listHide
ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.
Who can join AIAdults (age ≥18) with primary immune thrombocytopenia (ITP) or primary Evans syndrome (ES) who meet the study's treatment and lab criteria.
What is being studied AITests tolerability of ianalumab plus TPO‑RA in people with ITP or Evans syndrome.
Who can join AIAdults (≥18) with immune thrombocytopenia or related autoimmune forms (including Evans syndrome and connective-tissue–related ITP) with platelets <30×10^9/L who failed or cannot take eltrombopag or herombopag.
What is being studied AITests avatrombopag treatment for adults with immune thrombocytopenia and autoantibodies after failing eltrombopag/herombopag.